A detailed history of Tennessee Valley Asset Management Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Tennessee Valley Asset Management Partners holds 300 shares of LLY stock, worth $234,594. This represents 0.04% of its overall portfolio holdings.

Number of Shares
300
Previous 373 19.57%
Holding current value
$234,594
Previous $337,000 21.36%
% of portfolio
0.04%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $56,366 - $70,081
-73 Reduced 19.57%
300 $265,000
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $54,365 - $68,178
75 Added 25.17%
373 $337,000
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $176,475 - $236,099
298 New
298 $231,000
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $162,808 - $191,930
310 New
310 $180,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $743B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tennessee Valley Asset Management Partners Portfolio

Follow Tennessee Valley Asset Management Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tennessee Valley Asset Management Partners, based on Form 13F filings with the SEC.

News

Stay updated on Tennessee Valley Asset Management Partners with notifications on news.